RecruitingPhase 1NCT05687123
Endocrine
Neuroendocrine carcinoma of pancreas
94
studies recruiting now
as of 7 Sept 2026
438
studies registered in total
as of 7 Sept 2026
22
countries with a recruiting site
as of 7 Sept 2026
1 May 2023
most recent study posted
among recruiting studies
Recruiting trials
RecruitingPhase 2NCT04924075
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
RecruitingNCT05334069
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingNot applicableNCT05837767
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
RecruitingPhase 2NCT01174121
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 94 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Neuroendocrine carcinoma of pancreas study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Neuroendocrine carcinoma of pancreas
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Treatments being studied
7 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Phase 3Sunitinib Malate (Sunitinib malate)
Phase 2Sunitinib (Sunitinib accord)
Phase 2Etoposide (Etoposide)
Phase 2Capecitabine (Capecitabine)
Phase 2Cisplatin (Cisplatin)
Phase 2Temozolomide (Temodal)
Phase 2Carboplatin (Carboplatin)
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).